Skip to content

Applying mHealth to Tobacco-related Health Disparities

Applying mHealth to Tobacco-related Health Disparities: Enhancing Aspects of Resiliency to Aid Cessation Efforts (Time2Quit)

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03404596
Acronym
Time2Quit
Enrollment
50
Registered
2018-01-19
Start date
2018-07-16
Completion date
2020-12-14
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

cigarettes, quit smoking, nicotine, mindfulness, mHealth, mobile health

Brief summary

The purpose of this study is to better understand what happens when someone attempts to quit smoking.

Detailed description

Investigators will provide participants with nicotine patches, smoking cessation treatment that will include brief counseling sessions (10-15 minutes each), and text messages sent to their provided study phone throughout the day. These messages will be short (1-3 minutes long) and will ask participants to do things like focus on the present moment, pay attention to their breathing, and be aware of their current thoughts. Participants will be asked to wear equipment throughout the day that will measure their physiology and smoking behavior. Mobile Health (mHealth) is a general term for the use of mobile phones and other wireless technology in medical care. The key outcome and hypothesized mechanisms (i.e., lapse and stress) will be measured objectively and automatically using AutoSense. AutoSense is a type of human sensing technology that allows investigators to detect smoking behavior and stress objectively through a chest strap and wrist bands worn by participants. Ecological momentary assessment (EMA) will assess acute precipitants such as negative affect, craving, self-efficacy, motivation, alcohol consumption, etc. Questionnaires will assess other predictors and mechanisms.

Interventions

DRUGNicotine Patch

Nicotine patches and thorough education of the indications for the patch will be provided to all participants.

BEHAVIORALCounseling

Brief counseling sessions, 10-15 minutes each.

BEHAVIORALSmartphone

Ecological momentary assessment (EMA) assesses participants' moment-to-moment subjective experiences via self-report assessments on a smart phone. Participants will receive mindfulness strategies for 10 days pre- and post-quit via smart phone to aid in their cessation attempt. Text messages will be sent to provided study phones throughout the day. These messages will be short (1-3 minutes long) and will ask participants to do things like focus on the present moment, pay attention to their breathing, and be aware of their current thoughts.

OTHERAutoSense

Participants will be asked to wear equipment throughout the day that will measure their physiology and smoking behavior. AutoSense unobtrusively and objectively collects physiological and behavioral data (i.e., negative affect (NA), self-regulatory capacity (SRC), and smoking) via wearable chest and wrist sensors.

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Smoked a minimum of 3 cigarettes per day over the past year * Expired carbon monoxide reading ≥ 6 * Motivated to quit within the next 30 days * Valid home address * Functioning telephone number * Can speak, read, and write in English * At least marginal health literacy

Exclusion criteria

* Contraindication for the nicotine patch (e.g., heart attack, angina, skin allergies) unless a doctor's note is provided * Endorse current psychosis * Have a pacemaker or implanted device * Physically unable to wear equipment and provide a good reading of physiological measures * Current use of tobacco cessation medications * Current use of of smoking products other than cigarettes and e-cigarettes * Involvement in a smoking program or currently trying to quit * Pregnancy or lactation * Another household member being enrolled in the study * No prior experience with a smart phone * The study staff or principal investigator (PI) have serious concerns about the participant's ability to engage in and/or complete the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Rate of Smoking LapseUp to 36 monthsLapse will be measured objectively and automatically from the equipment worn by participants (AutoSense).
Rate of StressUp to 36 monthsStress will be measured objectively and automatically from the equipment worn by participants (AutoSense).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026